عرض بسيط للتسجيلة

المؤلفFatima, Kaneez
المؤلفMathew, Shilu
المؤلفFaheem, Muhammed
المؤلفMehmood, Tahir
المؤلفYassine, Hadi Mohamad
المؤلفAl Thani, Asmaa A
المؤلفAbdel-Hafiz, Hany
المؤلفAl Ghamdy, Khalid
المؤلفQadri, Ishtiaq
تاريخ الإتاحة2018-09-23T07:04:29Z
تاريخ النشر2018-09
اسم المنشورCurrent Pharmaceutical Design
المعرّفhttp://dx.doi.org/10.2174/1381612824666180911114210
الاقتباسKaneez Fatima, Shilu Mathew, Muhammed Faheem, Tahir Mehmood, Hadi Mohamad Yassine, Asmaa A. Al Thani, Hany Abdel-Hafiz, Khalid Al Ghamdy and Ishtiaq Qadri*. Current Pharmaceutical Design (2018) 24: 1. https://doi.org/10.2174/1381612824666180911114210
الرقم المعياري الدولي للكتاب1381-6128
معرّف المصادر الموحدhttp://hdl.handle.net/10576/11096
الملخصThe FOXO (Forkhead box O) transcription factors are implicated in several signaling pathways and play a vital role in various cellular and physiological processes include for instance, ROS (reactive oxygen species) response, cell proliferation, regulation of programmed cell death, longevity, metabolism and cancer and regulation of cell cycle. In humans, the four FOXO family members are responsible for resemblance in their structure, regulation and functions. FOXO1 gene is highly expressed in adipose tissues and it affects the regulation of glycogenolysis and gluconeogenesis through insulin signaling. The gene of FOXO3 is highly expressed in the kidney, heart, spleen and brain and is characterized as diverse forkhead DNA-binding domain of transcription factors. The FOXO3 is a tumor suppressor gene and found to interact with p53, the trigger for apoptosis through BCl2 family genes and a regulator of Notch signaling pathway for the self-renewal of stem cells. Therefore, FOXOs remains to be a fascinating and potential target to acquire novel therapeutic approaches to cure cancer. This review will provide a comprehensive overview about the biology of FOXO proteins, which can be utilized for developing current therapeutic approaches to treat cancer.
اللغةen
الناشرBentham Science Publishers
الموضوعForkhead box O
Therapeutic
Cancer
Polymorphism
Transcription factors
العنوانThe Dual Specificity Role of Transcription Factor FOXO in Type 2-diabetes and Cancer
النوعArticle Review
الصفحات1-10
رقم المجلد24
ESSN1873-4286
dc.accessType Abstract Only


الملفات في هذه التسجيلة

الملفاتالحجمالصيغةالعرض

لا توجد ملفات لها صلة بهذه التسجيلة.

هذه التسجيلة تظهر في المجموعات التالية

عرض بسيط للتسجيلة